FR5801M - - Google Patents

Info

Publication number
FR5801M
FR5801M FR67051A FR67051A FR5801M FR 5801 M FR5801 M FR 5801M FR 67051 A FR67051 A FR 67051A FR 67051 A FR67051 A FR 67051A FR 5801 M FR5801 M FR 5801M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR67051A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR67051A priority Critical patent/FR5801M/fr
Application granted granted Critical
Publication of FR5801M publication Critical patent/FR5801M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
FR67051A 1966-06-27 1966-06-27 Expired FR5801M (xx)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR67051A FR5801M (xx) 1966-06-27 1966-06-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR67051A FR5801M (xx) 1966-06-27 1966-06-27

Publications (1)

Publication Number Publication Date
FR5801M true FR5801M (xx) 1968-02-19

Family

ID=8611858

Family Applications (1)

Application Number Title Priority Date Filing Date
FR67051A Expired FR5801M (xx) 1966-06-27 1966-06-27

Country Status (1)

Country Link
FR (1) FR5801M (xx)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057863A2 (en) * 1999-03-25 2000-10-05 Medicure Inc. Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
WO2000057863A3 (en) * 1999-03-25 2001-04-05 Medicure Inc Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
WO2000057863A2 (en) * 1999-03-25 2000-10-05 Medicure Inc. Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Similar Documents

Publication Publication Date Title
AU5917865A (xx)
AU428063B2 (xx)
AU424443B2 (xx)
AU414526B2 (xx)
AU433222B2 (xx)
AU421822B2 (xx)
AU417216B2 (xx)
AU415165B1 (xx)
AU1144366A (xx)
AU6703465A (xx)
AU612166A (xx)
AU1111066A (xx)
AU5895065A (xx)
AU218666A (xx)
BE284991A (xx)
BE597652A (xx)
AU433620A (xx)
AU2390066A (xx)
AU415780B2 (xx)
AU407778B2 (xx)
BE674882A (xx)
AU411645B2 (xx)
AU6852465A (xx)
AU855865A (xx)
AU92366A (xx)